Ensifentrine Patent Expiration

Ensifentrine was first introduced by Verona Pharma Inc in its drug Ohtuvayre on Jun 26, 2024.

Ensifentrine Patents

Given below is the list of patents protecting Ensifentrine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Ohtuvayre	US10945950	Liquid inhalation formulation comprising RPL554	Sep 15, 2035	Verona Pharma
Ohtuvayre	US9956171	Liquid inhalation formulation comprising RPL554	Sep 15, 2035	Verona Pharma
Ohtuvayre	US9062047	Crystalline form of pyrimido[6,1-A] isoquinolin-4-one compound	Aug 21, 2031	Verona Pharma

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List